HBV Mutation Detail Information

> I195M Search Result


Mutation Information
Mutation Site I195M
Mutation Type Amino acid level
Gene/Protein/Region Type S
Genotype/Subtype B
Relevant Drug lamivudine (LAM)
Country China
Literature Information
PubMed PMID 12727536
Disease Chronic hepatitis B
Published Year 2003
Journal Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Title Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failure.
Author Ayres A,Bartholomeusz A,Lau G,Lam KC,Lee JY,Locarnini S
Evidence Subsequent to the instigation of antiviral therapy, the dominant drug resistant HBV which caused virological breakthrough and was associated with hepatic failure displayed a series of unique mutations particularly in the BCP (A1762T and G1764A) and in the polymerase (rtL180M, rtM204V, rtA222T and rtL336V), core (cP5T, cS26A, cV85I and cP135A), surface (sI195M and sM213I) and X (xK95Q, xN118T, xK130M and xV131I) proteins.

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation